NCT06293092

Brief Summary

the purpose of this study is to compare between intradialytic aerobic versus resistive exercises on immunity response in patients with chronic kidney disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 5, 2024

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

February 13, 2024

Last Update Submit

March 1, 2024

Conditions

Keywords

ExerciseDialysisKidney FailureChronic

Outcome Measures

Primary Outcomes (5)

  • Concentration of immunoglobulin g

    measured by mg/dl

    baseline , 12 weeks for each patient

  • Total leukocyte count

    measured by (cell/mcl)\*\*\*\*1000

    baseline , 12 weeks for each patient

  • lymphocyte count

    measured by (cell/mcl)\*\*\*\*1000

    baseline , 12 weeks for each patient

  • neutrophil count

    measured by (cell/mcl)\*\*\*\*1000

    baseline , 12 weeks for each patient

  • Concentration of HbA1c

    measured by percentage of blood sugar last 3 months

    baseline , 12 weeks for each patient

Secondary Outcomes (6)

  • hemoglobin concentration

    baseline , 12 weeks for each patient

  • thrombocytes count

    baseline , 12 weeks for each patient

  • diastolic blood pressure

    baseline , 12 weeks for each patient

  • Systolic blood pressure

    baseline , 12 weeks for each patient

  • six minute walk test

    baseline , 12 weeks for each patient

  • +1 more secondary outcomes

Study Arms (3)

control group C

EXPERIMENTAL

receive hemodialysis sessions

Device: hemodialysis sessions

study group A aerobic exercise

EXPERIMENTAL

receive hemodialysis sessions and intradialytic aerobic exercise

Device: leg pedaling cycling deviceDevice: hemodialysis sessions

study group B resistive exercise

EXPERIMENTAL

receive hemodialysis sessions and intradialytic resistive exercise

Device: sand bagsDevice: hemodialysis sessions

Interventions

Intradialytic aerobic cycling exercise program ,each patient will receive the treatment program three times per week for three months.

study group A aerobic exercise
sand bagsDEVICE

Intradialytic resistive exercise program , each patient will receive the treatment program three times per week for three months.

study group B resistive exercise

hemodialysis sessions ,each patient will receive the treatment program three times per week for three months.

control group Cstudy group A aerobic exercisestudy group B resistive exercise

Eligibility Criteria

Age50 Years - 60 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sixty men chronic kidney disease (grade III RF). They received regular hemodialysis sessions at least one year ago, each one for four hours, three times per week.
  • They had a history of type II Diabetes more than five years.
  • Their age will be ranged from 50-60 years old.
  • They are Fit for exercise by functional assessment using six minute walk test.
  • Their Hemoglobin level more than 10 g\\dl.
  • Their Body Mass Index (BMI) will be ranged from "18.5" to "24.9".

You may not qualify if:

  • Severe cardiac disorders.
  • Severe orthopedic problems (for example fractures).
  • Hepatic encephalopathy.
  • Preexisting neuromuscular diseases (e.g. myasthenia gravis). •Severe chest diseases.
  • Spinal cord injuries involved the phrenic nerve.
  • Uncontrolled diabetes or hypertension
  • Patients receiving inefficient hemodialysis session.
  • Patients with other cause for inflammation e.g. malignancy and autoimmune disease.
  • Active bleeding as alveolar hemorrhage, hemoptysis.
  • Physical limitation that would limit cycling.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum hospital

Al Fayyum, Egypt

Location

MeSH Terms

Conditions

Motor ActivityRenal InsufficiencyBronchiolitis Obliterans Syndrome

Condition Hierarchy (Ancestors)

BehaviorKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: control group receive medical treatment only ,first study group receive medical treatment and intradialytic aerobic exercise , second study group receive medical treatment and intradialytic resistive exercise
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physiotherapist

Study Record Dates

First Submitted

February 13, 2024

First Posted

March 5, 2024

Study Start

April 30, 2022

Primary Completion

October 30, 2023

Study Completion

January 30, 2024

Last Updated

March 5, 2024

Record last verified: 2024-03

Locations